Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 12 of 12

List	Outcome	Time frame
Primary	Glycosylated hemoglobin (HbA1c)	Change from baseline to week 24, at week -2, 0, 8 and 24
Secondary	Self monitoring blood glucose concentration	6 points for 2 days prior to each visit (at week 0, 4, 8, 16 and 24)
Secondary	Fasting blood glucose concentration	At week -2, 0, 4, 8, 16 and 24
Secondary	Blood concentration of triglyceride	At week -2 and 24
Secondary	Blood concentration of low density lipoprotein	At week -2 and 24
Secondary	Blood concentration of total cholesterol	At week -2 and 24
Secondary	Blood concentration of high density lipoprotein	At week -2 and 24
Secondary	Blood concentration of apolipoprotein A-1	At week -2 and 24
Secondary	Blood concentration of apolipoprotein B	At week -2 and 24
Secondary	Blood concentration of Glucagon-like peptide-1 (GLP-1)	At week -0 and 24
Secondary	Body weight, Body Mass Index(BMI)	At week -2, 0, 4, 8, 16 and 24
Secondary	High Sensitivity C-reactive protein (hs-CRP)	At week -2 and 24

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00970528/registered